Serodiscordance and disclosure among HIV-positive pregnant women in the Southwestern United States

AIDS Patient Care and STDs

Volumn 27, Issue 4, 2013, Pages 242-247

  Nacius, Lori A ^a   Levison, Judy ^a   Minard, Charles G ^a   Fasser, Carl ^a   Davila, Jessica A ^a,b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; ELECTRONIC MEDICAL RECORD; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; INTERPERSONAL COMMUNICATION; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; PREGNANT WOMAN; PRENATAL CARE; PREVALENCE; UNITED STATES;

ADULT; FEMALE; HIV; HIV SERONEGATIVITY; HIV SEROPOSITIVITY; HOSPITALS, COUNTY; HUMANS; MALE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PRENATAL CARE; PREVALENCE; RETROSPECTIVE STUDIES; SEXUAL PARTNERS; SOCIAL STIGMA; SOCIOECONOMIC FACTORS; SOUTHWESTERN UNITED STATES; TEXAS; TRUTH DISCLOSURE; VIRAL LOAD;

EID: 84876100918     PISSN: 10872914     EISSN: 15577449     Source Type: Journal    
DOI: 10.1089/apc.2012.0416     Document Type: Article

References (27)

1. AIDS Epidemic Update 2009. http://data.unaids.org/pub/Report/2009/JC1700- Epi-Update2009.pdf. Accessed January 2013.
2. Parra EO, Doran TI, Ivy LM, et al. Concerns of pregnant women about being tested for HIV: A study in a predominately Mexican-American population. AIDS Patient Care STDS 2001;15:83-93. (Pubitemid 32164610)
3. Mantell JE, Smit JA, Stein ZA. The right to choose parenthood among HIV-infected women and men. J Public Health Policy 2009;30:367-378.
4. Cliffe S, Townsend CL, Cortina-Borja M, et al. Fertility intentions of HIV-infected women in the United Kingdom. AIDS Care 2011;23:1093-1101.
5. Barreiro P, Castilla JA, Labarga P, et al. Is natural conception a valid option for HIV-serodiscordant couples? Hum Reprod 2007;22:2353-2358. (Pubitemid 47289050)
6. Warszawski J, Tubiana R, Le Chenadec J, et al. Mother-tochild HIV transmission despite antiretroviral therapy in the ANRS French Perinatal Cohort. AIDS 2008;22:289-299.
7. When One Partner is HIV + . http://aids.gov/hiv-aidsbasics/prevention/ reduce-your-risk/magnetic/couples/. Accessed January 2013.
8. Heard I, Sitta R, Lert F. Reproductive choice in men and women living with HIV: Evidence from a large representative sample of outpatients attending French hospitals (ANRS-EN12-VESPA Study). AIDS 2007;21:S77-S82. (Pubitemid 44970341)
9. Chen JL, Philips KA, Kanouse DE, et al. Fertility desires and intentions of HIV-positive men and women. Fam Plann Perspect 2001;33:144-152,165.
10. Lampe MA, Smith DK, Anderson GJ, et al. Achieving safe conception in HIV-discordant couples: The potential role of oral preexposure prophylaxis (PrEP) in the United States. Am J Obstet Gynecol 2011;204:488.
11. Ezeanochie M, Olagbuji B, Ande A, et al. Fertility preferences, condom use, and concerns among HIV-positive women in serodiscordant relationships in the era of antiretroviral therapy. Int J Gynaecol Obstet 2009;107:97-98.
12. Saxton J, Malyuta R, Semenenko I, et al. Previous reproductive history and post-natal family planning among HIV-infected women in Ukraine. Hum Reprod 2010;25: 2366-2373.
13. Cohen MS. Preventing sexual transmission of HIV. Clin Infect Dis 2007;45:S287-S292. (Pubitemid 351417231)
14. Matthews LT, Baeten JM, Celum C, et al. Periconception preexposure prophylaxis to prevent HIV transmission: Benefits, risks, and challenges to implementation. AIDS 2010;24:1975-1982.
15. Cohen MS, Chen YQ, McCauley M, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med 2011;365:493-505.
16. Baeten JM, Kahle E, Lingappa JR, et al. Genital HIV-1 RNA predicts risk of heterosexual HIV-1 transmission. Sci Transl Med 2011;3:77ra29.
17. Pre-Exposure Prophylaxis (PrEP). http://aids.gov/hiv-aidsbasics/ prevention/emerging-topics/pre-exposure-prophylaxis. Accessed January 2013.
18. Grant RM, Lama JR, Anderson PL, et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med 2010;363:2587-2599.
19. TDF2 Study, CDC Trial and another major study find PrEP can reduce risk of HIV infection among heterosexuals. http://www.cdc.gov/nchhstp/newsroom/ PrEPHeterosexuals .html. Accessed January 2013.
20. Partners PrEP Study, University of Washington International Clinical Research Center. http://depts.washington .edu/uwicrc/whats-new/index.html#prep. Accessed January 2013.
21. Siriwasin, W., Shaffer, N., Roongpisuthipong, A., et al. HIV prevalence, risk, and partner serodiscordance among pregnant women in Bangkok. Bangkok Collaborative Perinatal HIV Transmission Study Group. JAMA 1998; 280:49-54. (Pubitemid 28414996)
22. Makin JD, Forsyth BW, Visser MJ, et al. Factors affecting disclosure in South African HIV-positive pregnant women. AIDS Patient Care STDS 2008;22:907-916.
23. Visser MJ, Neufeld S, Makin JD, et al. To tell or not to tell: South African women's disclosure of HIV status during pregnancy. AIDS Care 2008;20:1138-1145.
24. Olagbuji BN, Ezeanochie MC, Agholor KN, et al. Spousal disclosure of HIV serostatus among women attending antenatal care in urban Nigeria. J Obstet Gynaecol 2011;31: 486-488.
25. Roxby AC, Matemo D, Drake A, et al. Pregnant women and disclosure to sexual partners after testing HIV-1-seropositive during antenatal care. AIDS Patient Care STDS 2013;27: 33-37.
26. Serovich JM, Craft SM, Reed SJ. Women's HIV disclosure to family and friends. AIDS Patient Care STDS 2012;26:241-249.
27. Moses S, Tomlinson M. The fluidity of disclosure: A longitudinal exploration of women's experience and understanding of HIV disclosure in the context of pregnancy and early motherhood. AIDS Care 2012 Oct 30 [Epub ahead of print], PMID: 23110311.